Regulation of TRPML1 channel activity and inflammatory exosome release by endogenously produced reactive oxygen

Guangbi Li1, Dandan Huang1, Ningjun Li1

  • 1Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.

Redox Biology
|May 24, 2021
PubMed

Insights

Hyperhomocysteinemia elevates reactive oxygen species (ROS) in podocytes, inhibiting TRPML1 channels and promoting inflammatory exosome release. This mechanism contributes to glomerular inflammation by increasing NLRP3 inflammasome product secretion.

Area of Science:

  • Nephrology
  • Cell Biology
  • Immunology

Background:

  • The NLRP3 inflammasome in podocytes initiates glomerular inflammation in hyperhomocysteinemia (hHcy).
  • The release mechanism of NLRP3 inflammasome products from podocytes is currently unknown.
  • NADPH oxidase-derived reactive oxygen species (ROS) are investigated as a potential mediator of inflammatory cytokine release.

Purpose of the Study:

  • To investigate if NADPH oxidase-produced ROS enhance exosome secretion from podocytes.
  • To elucidate the role of ROS in the release of inflammatory cytokines via the NLRP3 inflammasome in podocytes following Hcy stimulation.
  • To determine the impact of Hcy on TRPML1 channel activity and lysosomal Ca2+ release in podocytes.

Main Methods:

  • Assessed ROS production in Hcy-treated podocytes using NADPH oxidase inhibitors (gp91 ds-tat, DPI) and a ROS scavenger (catalase).
  • Evaluated NLRP3 inflammasome activation and multivesicular body (MVB) formation in podocytes.
  • Utilized GCaMP3 Ca2+ imaging to assess TRPML1 channel activity and lysosomal Ca2+ release.
  • Employed structured illumination microscopy (SIM) and nanoparticle tracking analysis (NTA) to study lysosome-MVB interaction and exosome secretion.

Main Results:

  • Hcy significantly increased ROS production in podocytes, which was blocked by NADPH oxidase inhibitors and catalase.
  • Hcy induced NLRP3 inflammasome activation and MVB formation, effects reversed by gp91 ds-tat or catalase.
  • Hcy inhibited TRPML1 channel activity and lysosomal Ca2+ release, an effect ameliorated by catalase and gp91 ds-tat.
  • TRPML1 channel activation reduced exosome release, but this effect was attenuated by Hcy; ROS inhibition restored normal lysosome-MVB interaction and exosome secretion.
  • Hydrogen peroxide (H2O2) mimicked Hcy's effects on TRPML1, lysosome-MVB interaction, and exosome secretion.

Conclusions:

  • Endogenously produced ROS significantly contribute to inflammatory exosome secretion from podocytes.
  • ROS inhibit TRPML1 channel activity, disrupting normal exosome release pathways.
  • This ROS-mediated mechanism may play a crucial role in initiating glomerular inflammation during hyperhomocysteinemia.